Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/1998
05/07/1998WO1998018914A1 Soluble tie2 receptor
05/07/1998WO1998018825A1 Anti-p53 single-chain antibody fragments and their uses
05/07/1998WO1998018812A1 Oligomers which inhibit the expression of interleukin genes
05/07/1998WO1998018811A1 Delivery construct for antisense nucleic acids and methods of use
05/07/1998WO1998018810A1 Immunostimulatory nucleic acid molecules
05/07/1998WO1998018480A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
05/07/1998WO1998018323A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
05/07/1998WO1998012311A3 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
05/07/1998WO1998011243A3 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
05/07/1998WO1998008965A3 Cd95 regulatory gene sequences and transcription factors
05/07/1998WO1998007855A3 Secreted proteins and polynucleotides encoding them
05/07/1998WO1998006841A3 Two human nsp-like proteins
05/07/1998WO1998006746A3 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same
05/07/1998WO1998004242A3 Tumor delivery vehicles and method to enhance treatment of cystic tumors
05/07/1998WO1998003159A3 Lipid-binding proteins and their therapeutic and diagnostic use
05/07/1998WO1998002558A3 Chimeric receptors for jak-stat signal transduction
05/07/1998WO1997046683A3 Polynucleotides encoding secreted proteins
05/07/1998WO1997044461A3 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/07/1998CA2665133A1 Neutrokine .alpha.
05/07/1998CA2271720A1 Streptococcus pneumoniae polynucleotides and sequences
05/07/1998CA2270901A1 Delivery construct for antisense nucleic acids and methods of use
05/07/1998CA2270345A1 Immunostimulatory nucleic acid molecules
05/07/1998CA2269865A1 Process aimed at evidencing the state of a malignant cell and process for treatment
05/07/1998CA2269801A1 Stable expression of triple helical proteins
05/07/1998CA2269722A1 Oligomers which inhibit the expression of interleukin genes
05/07/1998CA2269663A1 Streptococcus pneumoniae antigens and vaccines
05/07/1998CA2269642A1 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
05/07/1998CA2268027A1 Novel flt-3 receptor agonists
05/07/1998CA2268023A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists
05/07/1998CA2268001A1 Circularly permuted erythropoietin receptor agonists
05/07/1998CA2265523A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
05/06/1998EP0839910A2 Spo-rel, a Staphylococcus relA/spot homologue
05/06/1998EP0839908A2 A novel human ETS family member, ELF3
05/06/1998EP0839831A2 Single chain gonadotropin
05/06/1998EP0839830A1 Polyether nucleic acids
05/06/1998EP0839207A2 p16 EXPRESSION CONSTRUCTS AND THEIR APPLICATION IN CANCER THERAPY
05/06/1998EP0839206A1 Cd4 gene regulatory sequences specifically expressed in mature t cells
05/06/1998EP0839205A1 Liver-specific adenovirus expression vector
05/06/1998EP0839196A2 Human ctla-8 and uses of ctla-8-related proteins
05/06/1998EP0839195A1 Nucleotide and peptide sequences for treating myasthenia
05/06/1998EP0839194A1 Protein p53 variants and their therapeutic uses
05/06/1998EP0839125A1 Novel cationic lipids and the use thereof
05/06/1998EP0839055A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
05/06/1998EP0839054A1 Tumor- or cell-specific herpes simplex virus replication
05/06/1998EP0788364A4 Treatment of urogenital cancer with boron neutron capture therapy
05/06/1998EP0742790A4 Substituted purines and oligonucleotide cross-linking
05/06/1998EP0711355A4 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
05/06/1998CN1181021A Method and compositions for regulation of CD28 expression
05/06/1998CN1180745A New carrier for gene treatment
05/06/1998CN1180709A Neopolynucleotide and polypeptide gene of genetic multiple exogenetic bone wart family
05/05/1998US5747663 Process for the depletion or removal of endotoxins
05/05/1998US5747655 Nerve cells, geonomes dna sequences and amino acid sequences
05/05/1998US5747471 Cationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic molecules
05/05/1998US5747470 Anticarcinogenic agents, viricides
05/05/1998US5747469 Methods and compositions comprising DNA damaging agents and p53
05/05/1998US5747325 Artificial cells for treatment of diabetes to form insulin
05/05/1998US5747319 Human mRNA editing enzyme
05/05/1998US5747318 Mitogen activated c-Fos regulating kinase, FRK
05/05/1998US5747315 DNA encoding aspartyl tRNA synthetase from Streptococcus pneumoniae
05/05/1998US5747314 Nucleotides and genetic vectors
05/05/1998US5747313 DNA encoding histidyl tRNA synthetase from Streptococcus pneumoniae
05/05/1998US5747312 Dna and rna codes for genetic engineering and treatment of mutations and diseases
05/05/1998US5747307 Mason-Pfizer Monkey Retroviral packaging defective vectors
05/05/1998US5747286 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae
05/05/1998US5747282 Dna and cloning vectors for production of cloning vectors and gene expression for screening potential cancer therapy
05/05/1998US5747280 Human vascular IBP-like growth factor
05/05/1998US5747250 Probe for tumour diagnostics or tumour therapy
05/05/1998US5747072 Adenoviral-mediated gene transfer to synovial cells in vivo
04/1998
04/30/1998WO1998017826A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus
04/30/1998WO1998017823A1 STRUCTURAL AND FUNCTIONAL CONSERVATION OF THE C. ELEGANS CLOCK GENE $i(clk-1)
04/30/1998WO1998017820A1 Vaccines
04/30/1998WO1998017818A1 Artificial polymeric membrane structure, method for preparing same, method for preparing this polymer, particle and film containing this structure
04/30/1998WO1998017817A1 Retroviral vectors
04/30/1998WO1998017816A1 Lentiviral vectors
04/30/1998WO1998017815A1 Retroviral vectors
04/30/1998WO1998017814A2 Gene expression and delivery systems and uses
04/30/1998WO1998017810A2 Multi-functional chimeric hematopoietic receptor agonists
04/30/1998WO1998017806A1 Mini-e1a genes and gene products
04/30/1998WO1998017802A1 RAINBOW TROUT IL1β; ENCODING NUCLEIC ACID; MATERIALS AND METHODS
04/30/1998WO1998017801A1 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-α NUCLEIC ACIDS
04/30/1998WO1998017799A1 Immunotherapy and improved vaccines
04/30/1998WO1998017796A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
04/30/1998WO1998017793A1 Fringe proteins and notch signalling
04/30/1998WO1998017784A1 Method for in vitro preconditioning of myoblasts before transplantation
04/30/1998WO1998017783A1 Improved adenovirus vectors
04/30/1998WO1998017779A1 NOVEL FabH
04/30/1998WO1998017693A1 Composition containing chitosan
04/30/1998WO1998017689A2 Il-12 gene expression and delivery systems and uses
04/30/1998WO1998017686A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use
04/30/1998WO1998017323A1 Improved vaccines
04/30/1998WO1998017322A1 Enhanced delivery of adenoviral vectors to lung tissue
04/30/1998WO1998017321A1 Gene delivery and expression in areas inaccessible to direct protein delivery
04/30/1998WO1998017320A1 Use of hyaluronan in gene therapy
04/30/1998WO1998017317A2 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates
04/30/1998WO1998017314A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
04/30/1998WO1998017309A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection
04/30/1998WO1998017308A1 Inhibiting hiv infection by cleaving co-receptor rna
04/30/1998WO1998017307A1 Method and composition for treating neuronal degeneration
04/30/1998WO1998017305A1 USE OF FasL OR FasL TRANSFECTED CD4+/FasL-/TH1-CELL LINES FOR THE TREATMENT OF TH1/TH2 DISEASES
04/30/1998WO1998017300A1 Mucin-mediated immunomodulation
1 ... 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 ... 870